Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Luke Austin

Orthopaedic Surgery Sewell, NJ Medical Doctor

NPI 1629195532 CMS profile 28669

243 Hurffville Crosskeys Rd, Sewell, NJ 08080

Open in the dashboard

General payments

$2,947,448

217 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$7,877,301

6 holdings reported · through program year 2025

Research they led as principal investigator

$11,080 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Luke Austin of Sewell, NJ is reported in the CMS Open Payments database as having received $2,947,448 across 217 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $11,080 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $7,877,301 across 6 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

13 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $887,009 45
2024 General $396,440 43
2023 General $519,384 46
2022 General $529,656 30
2021 General $583,071 26
2020 General $419 5
2019 General $31,469 22
2025 Ownership $1,373,794 1
2024 Ownership $1,373,794 1
2023 Ownership $1,373,794 1
2022 Ownership $1,262,793 1
2021 Ownership $1,252,049 1
2020 Ownership $1,241,077 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Luke Austin
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Luke Austin were reported at $887,009. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Luke Austin Orthopaedic Surgery median Middle half National median
2019 $31,469 $644 $140–$2,844 $163
2020 $419 $312 $75–$1,860 $114
2021 $583,071 $520 $117–$2,495 $132
2022 $529,656 $598 $128–$2,731 $149
2023 $519,384 $461 $128–$2,264 $160
2024 $396,440 $497 $134–$2,475 $164
2025 $887,009 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Ignite Orthopedics, LLC $1,823,837 37 payments
  2. DePuy Synthes Products, Inc. $935,747 20 payments
  3. Medical Device Business Services, Inc. $184,083 128 payments
  4. Arthrex, Inc. $1,364 3 payments
  5. Liberty Surgical, Inc $753 6 payments
  6. DePuy Synthes Sales Inc. $737 8 payments
  7. Eclipse Technology Solutions Inc. $246 3 payments
  8. Stryker Corporation $174 4 payments
  9. Catalyst OrthoScience $168 1 payment
  10. Exactech, Inc. $136 1 payment
  11. Other $204 6 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $2,178,423 25 payments
  2. Current or prospective ownership or investment interest $520,914 2 payments
  3. Consulting Fee $226,913 57 payments
  4. Travel and Lodging $15,052 54 payments
  5. Food and Beverage $4,947 78 payments
  6. Education $1,200 1 payment
Products named General payments · program years 2019–2025
  1. INHANCE $942,728 73 payments
  2. GLOBAL $174,408 58 payments
  3. BIOLOX DELTA $141,288 51 payments
  4. Endurance $1,169 6 payments
  5. ATTUNE $226 2 payments
  6. Catalyst Total CSR $168 1 payment
  7. DYNACORD $167 2 payments
  8. EQUINOXE $136 1 payment
  9. NA Sports Surgical $129 1 payment
  10. NA Ortho-Shoulder $129 1 payment
  11. Other $605 15 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 57 billing codes

Paid by Medicare

$228,630

Of which drugs: $883

Medicare patients

502

Average age 72

Services billed

2,922

264 women, 238 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 31%
Ischemic heart disease 25%
Depression 23%
Chronic kidney disease 18%
Cancer 16%
COPD 15%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 181 1,190 $883

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

217 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in New Jersey

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record